Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07464730
NA

Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult

Sponsor: Region Stockholm

View on ClinicalTrials.gov

Summary

High flow nasal oxygen (HFNO) in the immediate postoperative period has been demonstrated to reduce the risk of postoperative pulmonary complications (PPC) after cardiothoracic surgery. In specific groups of patients such as the obese and after upper abdominal surgery the results are contradictive. However, there is lack of evidence if HFNO in the general high-risk patient after abdominal and non-cardiac thoracic surgery can reduce the prevalence of PPC, hypoxaemia and escalation of therapy. Therefore, the investigators aim to compare the use of HFNO with conventional oxygen therapy (COT) in high-risk patients after abdominal and non-cardiac thoracic surgery regarding postoperative pulmonary complications.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2026-03-09

Completion Date

2029-03-09

Last Updated

2026-03-11

Healthy Volunteers

No

Interventions

COMBINATION_PRODUCT

High Flow Oxygen

High flow nasal oxygen will be administered in the intervention group

COMBINATION_PRODUCT

Oxygen

Oxygen delivered by nasal cannula or oxymask

Locations (1)

Karolinska University Hospital

Stockholm, Sweden